NCT04832100View on ClinicalTrials.gov

Bio-significance of LPC16:0 in Fibromyalgia

RecruitingOBSERVATIONAL
Enrollment

245

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Fibromyalgia, PrimaryPainSoreness, MuscleOxidative StressMetabolomicsLipidomics
Interventions
DRUG

Pregabalin 150mg, imipramine 25mg

Conventional treatment for fibromyalgia was given to patients. Clinical follow-ups with questionnaires and interview were arranged then.

Trial Locations (1)

80756

RECRUITING

Kaohsiung Medical University Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER